Type 2 Diabetes and Blood Brain Barrier Improvement
The majority of T2DM adults show thiamine (vitamin B1) deficiency which may contribute to impaired function. This study will examine patients with T2DM through brain MRI scans, cognition assessments, blood tests, and questionnaires. Our goal is to see if a thiamine treatment (taking vitamin B1 capsules) can improve function. Patients will be asked to come to UCLA two times three months apart and each visit will last about 2.5-3 hours.
Conditions studied
Type2diabetes
About this study
The majority of T2DM adults show thiamine (vitamin B1) deficiency which may contribute to impaired function. This study will examine patients with T2DM through brain MRI scans, cognition assessments, blood tests, and questionnaires. Our goal is to see if a thiamine treatment (taking vitamin B1 capsules) can improve function. Patients will be asked to come to UCLA two times three months apart and each visit will last about 2.5-3 hours.
Interventions
- Dietary Supplement: Thiamine — Participants will be provided instruction to take one 500 mg capsule of Thiamine (Vitamin B1) each day in the morning for 3-months.
- Other: Placebo — Participants will be provided instruction to take one capsule (placebo) each day in the morning for 3-months.
Primary outcomes
- Assess if BBB function has been repaired. (After 3 months)
- Analyze blood serum S100β levels. (After 3 months)
- Examine cognition in T2DM adults with thiamine treatment. (After 3 months)
- Cognition assessment in T2DM adults after thiamine treatment. (After 3 months)
- Examine depression in T2DM adults with thiamine treatment. (After 3 months)
- Assess anxiety in T2DM adults with thiamine treatment. (After 3 months)
Eligibility information
Study locations
- UCLA, Los Angeles, California 90095 United States
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.